Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference : vimarsana.com

Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference

WALTHAM, Mass., Feb. 28, 2024 -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with...

Related Keywords

Melissa Forst , Dan Budwick , Nasdaq , Xilio Therapeutics Inc , Linkedin Xilio Therapeutics Inc , Health Care Conference On , Annual Health Care Conference , Xilio Therapeutics ,